Author:
Mariani G.,Hilgartner M.,Thompson A. R.,Tusell J.,Manco-Johnson M.,Ghirardini A.,Bellocco R.,Brackmann H. H.
Reference19 articles.
1. S. Ehrenforth, W. Kreuz, I. Sharrer, R. Linde, M. Funk, T. Gungor, B. Krackhardt, and B. Kornhuber, Incidence of development of factor VIII and factor IX inhibitors in hemophiliacs, Lancet 339:594 (1992).
2. J.M. Lusher, S. Arkin, C.F. Abilgaard, R.S. Schwartz and the Kogenate Previously Untreated Patient Study Group, Recombinant Factor VIII for the treatment of previously untreated patients with hemophilia A, N. Engl. J. Med. 328:453 (1993).
3. J. P. Allain, D. Frommel, Antibodies to factor VIII. V. Patterns of immuneresponse to factor VIII in hemophilia A, Blood 47:973 (1976).
4. H. H. Brackmann, J. Gormsen, Massive factor-Vlriinfusion in hemophiliac with factor VIII inhibitor, high responder, Lancet 2:933 (1977).
5. H.H. Brackmann, Induced immune tolerance in factor VIII inhibitor patients, Progr Clin Biol Res 150:181 (1984).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献